%0 Journal Article %A Shawn L Hanlon %A Bradley C Bley %A Karin Grävare Silbernagel %T Determining the feasibility of exercise therapy and activity modification for treating adolescents with heel pain: a study protocol %D 2022 %R 10.1136/bmjsem-2021-001301 %J BMJ Open Sport & Exercise Medicine %P e001301 %V 8 %N 3 %X Calcaneal apophysitis and Achilles tendinopathy are common overuse injuries characterised by insidious posterior heel pain with activity. Calcaneal apophysitis is commonly diagnosed in adolescents, although Achilles tendinopathy is understudied in the adolescent population and is therefore rarely considered until adulthood. Exercise therapy and activity modification have the highest level of evidence for treating Achilles tendinopathy, while calcaneal apophysitis is treated with anecdotal and passive treatment or complete rest. It remains unknown whether exercise therapy is effective for adolescents with heel pain related to either diagnosis.This is a pilot and feasibility study. Thirty participants between the ages of 7 years and 17 years with posterior heel pain will be recruited from the local community and club sports team and local physicians, school nurses, and athletic trainers through flyers and social media. Participants will be asked to complete evaluations and treatment sessions every 4 weeks with three virtual visits every 2 weeks in between for 12 weeks. All participants will receive standardised treatment consisting of daily Achilles tendon loading exercises and education on pain-guided activity modification. Feasibility outcomes will include recruitment, enrolment, retention and compliance. Clinical outcomes will include the measures of symptom severity, quality of life, tendon morphology and lower extremity function.This protocol will provide preliminary data to inform a larger clinical trial based on the feasibility of the proposed intervention and methodology. Additionally, the results will provide preliminary evidence on whether Achilles tendon injury occurs in the adolescent population.The trial is registered with clinicaltrials.gov (ID:1652996).Data are available upon reasonable request. Data are available upon reasonable request to the corresponding author. %U https://bmjopensem.bmj.com/content/bmjosem/8/3/e001301.full.pdf